3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Prostatic Neoplasms
1
Pancreatic Cyst
1
Neuroblastoma
1
Nervous System Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Intestinal Neuroendocrine Tumor
1
Frailty
1
Financial Stress
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
Etoposide
27
Carboplatin
25
atezolizumab
16
durvalumab
12
Topotecan
9
Drug Therapy
9
Cisplatin
9
PM 01183
7
Radiotherapy
5
pembrolizumab
4
Specimen Handling
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Injections
4
Immunotherapy
4
trilaciclib
3
toripalimab
3
Temozolomide
3
Radiosurgery
3
Bevacizumab
3
AMG 757
3
tislelizumab
2
monalizumab
2
irinotecan sucrosofate
2
enzalutamide
2
apatinib
2
Platinum
2
Nivolumab
2
Itraconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Small Cell Lung Carcinoma
×
Data Collection
×
Clear all
NCT02622581
2025-02-18
CRISP
AIO-Studien-gGmbH
Recruiting
12,400 enrolled